Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

AmyvidHCP.com | Home

Description

Keywords

Amyvid, Alzheimer's Disease, diagnostic, beta-amyloid, amyloid, PET tracer, imaging, amyloid plaque, reader training, evidence, florbetapir f 18 injection

H1

AMYVIDHCP.COM IS INTENDED FOR US HEALTH CARE PROFESSIONALS ONLY
ASK LILLY
AMYVIDHCP.COM PDF DOWNLOAD:
REVEAL EVIDENCE OF AMYLOID PATHOLOGY WITH AMYVID

H2

REFERENCES
REFERENCES
IMPORTANT SAFETY INFORMATION:
AMYVID IS THE FIRST FDA-APPROVED DIAGNOSTIC PET TRACER FOR ESTIMATING BETA-AMYLOID NEURITIC PLAQUE DENSITY
INDICATIONS AND USAGE:
IMPORTANT SAFETY INFORMATION:

H3

WARNINGS AND PRECAUTIONS
MOST COMMON ADVERSE REACTIONS
WARNINGS AND PRECAUTIONS
MOST COMMON ADVERSE REACTIONS

H4

Risk for Image Misinterpretation and Other Errors
Radiation Risk
When evaluating for Alzheimer's Disease (AD) and other causes of cognitive decline
Risk for Image Misinterpretation and Other Errors
Radiation Risk

H5

Text Analysis

Cloud of Keywords from all content
High relevance
 

amyvid alzheimer disease care image scan brain neuritic errors health clinical amyloid plaque alzheimers radiation interpretation patients amyvidhcp diagnosis lilly institute diagnostic dementia cognitive dement hcp risk association imaging exposure

Medium relevance
 

adverse physician national prescribing resources cumulative patient density recommendations long-term negative common reactions development patient’s study acquisition guidelines white professional safety professionals case reader resources amyvidhcp evaluated package knopman neuropathological insert aging-alzheimer workgroups

Low relevance
 

reactions development patient’s study acquisition guidelines white professional safety professionals case reader resources amyvidhcp evaluated package knopman neuropathological insert aging-alzheimer workgroups geriatr ensure safe increased aging cancer handling criteria trials product 05oct2012 nausea training biomarkers neurol referring technologist fatigue musculoskeletal beta-amyloid unintentional workers jack reported decline headache protect neurology limits company atrophy extensive download ability sci gray distinguish lead images intended misinterpretation occur estimation performed warnings center additional independently matter references contributes boise figures facts kaye plaques impairment demen injection radiopharmaceuticals positive content indicative distort assessment neurologic motion group preclude artifacts

Very Low relevance
 
geriatr ensure safe increased aging cancer handling criteria trials product 05oct2012 nausea training biomarkers neurol referring technologist fatigue musculoskeletal beta-amyloid unintentional workers jack reported decline headache protect neurology limits company atrophy extensive download ability sci gray distinguish lead images intended misinterpretation occur estimation performed warnings center additional independently matter references contributes boise figures facts kaye plaques impairment demen injection radiopharmaceuticals positive content indicative distort assessment neurologic motion group preclude artifacts profiles future morereview responses monitoring condition therapies intravenous vials multidose supplied predicting established evaluations adjunct cognition limitations establish effectiveness disorder safety 500-1900 mbq rights llc map reserved am8249206 trademark 2013amyvid™ copyright terms future radiation precautions risk florbetapir exposure most reactions the statement privacy people older trainedcomplete estimating tracer program amyvidlocate profilesview nearest fda-approved pathology business faqs reimbursement manager evaluating evidence reveal studies indications moderate likelihood reduces frequent examination conditions types inconsistent sparse emission positron usage tomography estimate alzheimer’s adult availability knoxville early-onset proven pathologically morgan delays family perspectives genotype apoe hospital barcelona university clínic ntb features collaborative caregivers tsuang chow mok population-based zheng clinicopathological diagnoses concordance honolulu-asia accuracy clinico-neuropathological kukull correlation community-based petrovitch series bank tissue technical contained sitemap nature created answers questions amyvid amyvidhcp studies amyvidhcp home amyvidhcp home amyvidhcp advanced faqs amyvidhcp reimbursement amyvidhcp supply amyvidhcp training amyvidhcp 1-800-lillyrx 1-800-545-5979 continue document included balasa gelpi neurological antonell 4-page resource number toll-free connect service requested pdf community tertiary bracco princeton cardiogen-82 diagnostics sodium siemens fluoride medical feinstein working reagan postmortem neuropathol exp manhasset ammonia molecular neal worsening behavioral findings donepezil frontotemporal register psychiatry preliminary mcmurtray managed primary systems gerontol shapira mendez consensus editorial hypothetical jagust stages model dynamic cascade pathological preclinical defining albert clinicians introduction sperling beckett aisen lancet mckhann amy20121001a amy20120725 laboratories amy20121001b amy20121001q trojanowski hyman file data forlenza chertkow diniz gattaz bmc predementia precautions

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

Medium relevance
 

risk amyvid amyvidhcp

Low relevance
 

amyvid amyvidhcp errors radiation diagnostic misinterpretation beta-amyloid image adverse common precautions warnings reactions safety evidence references amyloid

Very Low relevance
 
errors radiation diagnostic misinterpretation beta-amyloid image adverse common precautions warnings reactions safety evidence references amyloid imaging amyloid plaque reader training florbetapir f 18 injection pet tracer cognitive evaluating disease alzheimer decline alzheimer's disease density lilly pdf download professionals care intended health reveal pathology plaque indications neuritic estimating fda-approved tracer usage